131 related articles for article (PubMed ID: 27601168)
21. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
22. Expression of Ras-related protein 25 predicts chemotherapy resistance and prognosis in advanced non-small cell lung cancer.
Ma YF; Yang B; Li J; Zhang T; Guo JT; Chen L; Li M; Chu J; Liang CY; Liu Y
Genet Mol Res; 2015 Oct; 14(4):13998-4008. PubMed ID: 26535714
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
25. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.
Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W
Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029
[TBL] [Abstract][Full Text] [Related]
26. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer.
Yin B; Zhang M; Zeng Y; Li Y; Zhang C; Getzenberg RH; Song Y
Int J Oncol; 2016 Apr; 48(4):1730-6. PubMed ID: 26892177
[TBL] [Abstract][Full Text] [Related]
29. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
[TBL] [Abstract][Full Text] [Related]
31. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
[TBL] [Abstract][Full Text] [Related]
32. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
Jiang F; Kuang B; Que Y; Lin Z; Yuan L; Xiao W; Peng R; Zhang X; Zhang X
Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241
[TBL] [Abstract][Full Text] [Related]
34. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of LIMK1 level inhibits migration of lung cancer cells and enhances sensitivity to chemotherapy drugs.
Chen Q; Jiao D; Hu H; Song J; Yan J; Wu L; Xu LQ
Oncol Res; 2013; 20(11):491-8. PubMed ID: 24063279
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
40. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]